Edition:
India

Biomerica Inc (BMRA.OQ)

BMRA.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
20 Sep 2019
Change (% chg)

$0.02 (+0.64%)
Prev Close
$3.13
Open
$3.13
Day's High
$3.20
Day's Low
$3.11
Volume
11,559
Avg. Vol
8,051
52-wk High
$3.77
52-wk Low
$1.60

Latest Key Developments (Source: Significant Developments)

Biomerica Signs Exclusive Distribution Agreement In China For Its Colorectal Screening Test
Wednesday, 5 Jun 2019 

June 5 (Reuters) - Biomerica Inc ::BIOMERICA SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT IN CHINA FOR ITS COLORECTAL SCREENING TEST WITH TOTAL MINIMUM PURCHASE REQUIREMENT OF $17 MILLION OVER 7 YEARS AND AN UPFRONT PRE-PAYMENT OF $1 MILLION..BIOMERICA INC - SIGNED AN EXCLUSIVE SALES AND DISTRIBUTION AGREEMENT WITH MAXHEALTH FOR SALE OF ITS EZ DETECT PRODUCT IN CHINA.  Full Article

Biomerica Announces Third Quarter Sales Of $1.261 Million Versus $1.376 Million
Tuesday, 16 Apr 2019 

April 16 (Reuters) - Biomerica Inc ::BIOMERICA ANNOUNCES THIRD QUARTER FINANCIAL RESULTS.Q3 SALES $1.261 MILLION VERSUS $1.376 MILLION.NET LOSS FOR THREE MONTHS ENDED FEBRUARY 28, 2019 WAS $678,746 COMPARED TO A NET LOSS OF $322,491.  Full Article

Biomerica - Francis Capitanio To Retire As President
Friday, 22 Mar 2019 

March 21 (Reuters) - Biomerica Inc ::BIOMERICA INC - FRANCIS CAPITANIO TO RETIRE, EFFECTIVE AS OF APRIL 5, 2019 AS PRESIDENT - SEC FILING.  Full Article

Biomerica Reports Q1 Net Sales Of $1.3 Million
Tuesday, 16 Oct 2018 

Oct 16 (Reuters) - Biomerica Inc ::BIOMERICA REPORTS 1ST QUARTER FISCAL 2019 FINANCIALS.BIOMERICA INC - QTRLY NET SALES OF $1.3 MILLION VERSUS $1.4 MILLION.BIOMERICA INC - QTRLY NET LOSS FOR $451,740 COMPARED TO NET LOSS OF $207,059 DURING SAME PERIOD IN FISCAL 2018.BIOMERICA INC - "SALES WERE NEGATIVELY IMPACTED BY LOWER SALES TO COMPANY'S EUROPEAN DISTRIBUTORS AND ORDER TIMING".  Full Article

Biomerica Says ‍Mexico's Cofepris' Approval Of EZ Detect Colorectal Screening Test​ - SEC Filing
Thursday, 8 Mar 2018 

March 8 (Reuters) - Biomerica Inc ::BIOMERICA SAYS ‍MEXICO'S COFEPRIS' APPROVAL OF EZ DETECT COLORECTAL SCREENING TEST​ - SEC FILING.BIOMERICA SAYS APPOINTED DNA BIOPHARMA (DNA) AS EXCLUSIVE DISTRIBUTOR FOR EZ DETECT PRODUCT IN MEXICO.  Full Article

Xiamen Red Phase Instruments to acquire 5 pct stake in electronics technology firm for 30.5 mln yuan
Thursday, 1 Mar 2018 

March 1(Reuters) - Xiamen Red Phase Instruments Inc <300427.SZ>:Says it plans to acquire 5 percent stake in a Shanghai-based electronics technology firm for 30.5 million yuan .  Full Article

Biomerica Q2 Loss Per Share $0.03
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Biomerica Inc ::BIOMERICA ANNOUNCES SECOND QUARTER FINANCIAL RESULTS; SALES UP 12.7% FOR THE QUARTER.Q2 LOSS PER SHARE $0.03.Q2 SALES ROSE 12.7 PERCENT TO $1.614 MILLION.  Full Article

China FDA Approves Biomerica Colorectal Screening Test To Help Identify The Early Warning Signs Of Colorectal Cancer
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Biomerica Inc ::CHINA FOOD AND DRUG ADMINISTRATION (CFDA) APPROVES BIOMERICA COLORECTAL SCREENING TEST TO HELP IDENTIFY THE EARLY WARNING SIGNS OF COLORECTAL CANCER.  Full Article

Biomerica extends license agreement with Celtis Pharm
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Biomerica Inc ::Biomerica extends exclusive license agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019.Biomerica Inc - has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea​.Biomerica - ‍term of exclusivity agreement is five years with an additional two years for telcon to receive Korean FDA clearance​.Biomerica - agreement may be cancelled if co has not obtained final clearance for sale of products in U.S. from FDA on or before December 31, 2019​.  Full Article

Biomerica Inc Q1 ‍net sales $1.4 million
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Biomerica Inc :Net sales of $1.4 million for three months ending August 31, 2017, an increase of 2.4%​.Net loss for three months ended August 31, 2017 was $207,059 compared to a net loss of $55,417 during same period in fiscal 2017​.  Full Article